Cerulean Pharma (CERU) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts CERU Hot Sheet
Join SI Premium – FREE
Cerulean Pharma (NASDAQ: CERU) reported Q2 EPS of ($0.37), $0.06 better than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Cerulean Pharma (CERU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
- Estee Lauder (EL) Tops Q4 EPS by 7c, Beats on Revenue
- TOYO Co., Ltd (TOYO) Misses Q2 EPS by 24c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
